Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 14, 2013; 19(22): 3481-3486
Published online Jun 14, 2013. doi: 10.3748/wjg.v19.i22.3481
Figure 1
Figure 1 Flow chart of patients disposition in de novo lamivudine and adefovir dipivoxil combination group and lamivudine monotherapy group. HBV: Hepatitis B virus; HCC: Hepatocellular carcinoma; ADV: Adefovir dipivoxil; LAM: Lamivudine.